Weekly Roundup: Delta Soars, Moderna Jumps, PTC Rises

• Delta Air Lines (DAL) shares rose more the 11% this past week after reinstating its profit outlook for the year. The carrier said travelers are coming back, prompting its stock to surge amid a fresh sense of confidence in the beaten-down US consumer. Delta expects an adjusted profit of $5.25 to $6.25 a share this year, according to a statement on Thursday as Delta reported better-than-expected second-quarter results.
  
  
• Moderna (MRNA) shareholders welcomed the news that US regulators approved Moderna Inc.’s COVID vaccine for children, but for a narrower group than before, continuing Robert F. Kennedy Jr.’s controversial policy that restricts access to the shots for some kids. The Food and Drug Administration gave full approval of the immunization for kids under 12 who are at increased risk from the disease, the company said in a statement. The stock rose more than 10% on the week.
• PTC Inc. (PTC) saw its stock rise nearly 10% on the week on news that Autodesk Inc. is weighing an acquisition of the rival engineering-software provider, according to people familiar with the matter. Autodesk has been working with advisers to evaluate a cash-and-stock deal for Boston-based PTC, said the people, who asked to not be identified because the matter isn’t public. PTC, with a market value of about $23 billion, is also said to be drawing interest from other industry players.

See omnystudio.com/listener for privacy information.